Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Apellis Pharmaceuticals Inc (APLS)

  • SEC News
  • Sept. 02, 2025, 19:56 UTC
  • 5
  • 0 comments

New Form 144 - Apellis Pharmaceuticals, Inc. Filed: 2025-09-02 AccNo: 0001959173-25-005698 Size: 4 KB

Comment Full text

Surgery Partners Inc (SGRY)

  • SEC News
  • Sept. 02, 2025, 19:54 UTC
  • 5
  • 0 comments

New Form 144 - Surgery Partners, Inc. Filed: 2025-09-02 AccNo: 0001969223-25-000694 Size: 6 KB

Comment Full text

U.S. Neurosurgical Holdings, Inc. (USNU)

  • SEC News
  • Sept. 02, 2025, 19:49 UTC
  • 5
  • 0 comments

New Form PRE 14A - Elite Health Systems Inc. Filed: 2025-09-02 AccNo: 0001437749-25-028137 Size: 1 MB

Comment Full text

ResMed Inc (RMD)

  • SEC News
  • Sept. 02, 2025, 19:42 UTC
  • 8
  • 0 comments

New Form 3 - RESMED INC Filed: 2025-09-02 AccNo: 0001127602-25-021065 Size: 7 KB

Comment Full text

ResMed Inc (RMD)

  • Business News
  • Sept. 02, 2025, 19:42 UTC
  • 2
  • 0 comments

New SEC Form for ResMed Inc.

Market reaction Comment Full text

Myomo Inc (MYO)

  • Business News
  • Sept. 02, 2025, 19:31 UTC
  • 2
  • 0 comments

Webinars

Market reaction Comment Full text

Agilent Technologies Inc. (A)

  • SEC News
  • Sept. 02, 2025, 19:31 UTC
  • 7
  • 0 comments

New Form 144 - AGILENT TECHNOLOGIES, INC. Filed: 2025-09-02 AccNo: 0001959173-25-005693 Size: 8 KB

Comment Full text

U.S. Neurosurgical Holdings, Inc. (USNU)

  • SEC News
  • Sept. 02, 2025, 19:25 UTC
  • 8
  • 0 comments

New Form 8-K - Elite Health Systems Inc. Filed: 2025-09-02 AccNo: 0001437749-25-028131 Size: 136 KB Item 1.01: Entry into a Material Definitive Agreement

Comment Full text

Immunoprecise Antibodies Ltd (IPA)

  • Business News
  • Sept. 02, 2025, 19:17 UTC
  • 4
  • 0 comments

ImmunoPrecise Antibodies participera à la 27e conférence annuelle mondiale des investisseurs organisée par H.C. Wainwright à New York

Market reaction Comment Full text

Air Products and Chemicals Inc (APD)

  • Business News
  • Sept. 02, 2025, 19:16 UTC
  • 4
  • 0 comments

Air Products New Cleveland Air Separation Facility and Liquefier Onstream and Supplying Onsite and Regional Customers

Market reaction Comment Full text

Arcutis Biotherapeutics (ARQT)

  • SEC News
  • Sept. 02, 2025, 19:09 UTC
  • 6
  • 0 comments

New Form 144 - Arcutis Biotherapeutics, Inc. Filed: 2025-09-02 AccNo: 0002007317-25-001006 Size: 6 KB

Comment Full text

Iterum Therapeutics plc (ITRM)

  • Technical Exchange News
  • Sept. 02, 2025, 18:48 UTC
  • 10
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Celularity Inc. (CELUW)

  • Technical Exchange News
  • Sept. 02, 2025, 18:47 UTC
  • 10
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

Comment Full text

Celularity Inc. (CELU)

  • Technical Exchange News
  • Sept. 02, 2025, 18:47 UTC
  • 11
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

Comment Full text

Penumbra Inc (PEN)

  • Business News
  • Sept. 02, 2025, 18:37 UTC
  • 4
  • 0 comments

When Work Becomes Personal: Penumbra Employee’s Grandmother Saved by Device He Helped Build

Market reaction Comment Full text
  • Previous
  • 382
  • 383
  • 384
  • 385
  • 386
  • Next

Search

News categories

  • Technical Exchange News(10125)
  • Event(435)
  • SEC News(171175)
  • FDA Approval(9501)
  • Company Report(721)
  • Business News(114113)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin